Fibrocell Announces Positive Feedback from Type B End-of-Phase 2 Meeting with FDA on Phase 3 Clinical Trial Design for FCX-007

Bud Bilanich
Success Coach

David Linetsky
Point-of-Care Marketing

Pat Purcell
Meeting Engagement

Daniel Sontupe
Market Access

Suma Ramadas, PhD
Medical Affairs

Frank Burrell
Scientific Storytelling

Amy Giles
Increasing Engagement

Joey Cohen
Medication Adherence

Stacey Gandler
Brand Nourishment

Paul Theisen
Patient Acquisition

Brenda Snow
Authentic Patient Voice

Liz Kane
Impactful Strategy

Matthew Durham
Omnidynamic Marketing

Matt Turner
Patient Affordability